These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1350124)

  • 21. Frequency of train-of-four stimulation influences neuromuscular response.
    Meretoja OA; Taivainen T; Brandom BW; Wirtavuori K
    Br J Anaesth; 1994 Jun; 72(6):686-7. PubMed ID: 7912949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of 'onset' and 'offset' of four non-depolarising neuromuscular blocking drugs.
    Feldman SA; Wu X; England A
    Anaesthesia; 1995 Jun; 50(6):510-3. PubMed ID: 7618664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium.
    Bevan DR; Smith CE; Donati F
    Anesthesiology; 1988 Aug; 69(2):272-6. PubMed ID: 2900612
    [No Abstract]   [Full Text] [Related]  

  • 24. Atracurium and vecuronium in emergency eye surgery.
    Mallaiah S; Eltringham RJ; Magauran DM
    Anaesthesia; 1986 Jan; 41(1):84-5. PubMed ID: 2868673
    [No Abstract]   [Full Text] [Related]  

  • 25. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamics of vecuronium, atracurium, tubocurarine and their combinations in the rat in vivo.
    Booij LH; van Egmond J; van de Pol F; Crul JF
    Eur J Anaesthesiol; 1985 Sep; 2(3):279-84. PubMed ID: 2866094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromuscular blocking agents and carotid body oxygen sensing.
    Jonsson M; Lindahl SG; Eriksson LI
    Adv Exp Med Biol; 2003; 536():135-40. PubMed ID: 14635659
    [No Abstract]   [Full Text] [Related]  

  • 30. The new neuromuscular blocking drugs are here.
    Savarese JJ
    Anesthesiology; 1981 Jul; 55(1):1-3. PubMed ID: 6113792
    [No Abstract]   [Full Text] [Related]  

  • 31. Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity?
    Nijs N; Duvaldestin P; Slavov V; Dhonneur G
    Acta Anaesthesiol Scand; 1998 Nov; 42(10):1175-9. PubMed ID: 9834800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relaxation: current controversy.
    Savarese JJ
    Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S1-4. PubMed ID: 2872951
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of atracurium and vecuronium given in continuous injection].
    Neidhardt A; Neidhardt-Audion M; Bachour K
    Cah Anesthesiol; 1984 Dec; 32(8):645-8. PubMed ID: 6152194
    [No Abstract]   [Full Text] [Related]  

  • 34. The importance of myorelaxants in anesthesia.
    Flood P
    Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the neuromuscular and cardiovascular effects of vecuronium, atracurium and mivacurium in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):233-7. PubMed ID: 9690609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intubating conditions with atracurium, vecuronium and pancuronium.
    Schiller DJ; Feldman SA
    Anaesthesia; 1984 Dec; 39(12):1188-91. PubMed ID: 6151364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rocuronium onset of action: a comparison with atracurium and vecuronium.
    Bartkowski RR; Witkowski TA; Azad S; Lessin J; Marr A
    Anesth Analg; 1993 Sep; 77(3):574-8. PubMed ID: 8103649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants.
    Hilgenberg JC
    Anesth Analg; 1983 May; 62(5):524-31. PubMed ID: 6132564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.